Congress is poised to begin voting on a sweeping biomedical innovation bill that includes nearly $5 billion in dedicated funding for a trio of major research initiatives at the National Institutes of Health (NIH). The bill also includes measures to speed the approval of new drugs and medical devices by the Food and Drug Administration (FDA), and it would create a mechanism for catalyzing efforts to streamline federal regulations that universities and academic researchers regard as burdensome.
